Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Hallberg P, Karlsson J, Lind L, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H. Hallberg P, et al. Among authors: ohman kp. Clin Cardiol. 2004 May;27(5):287-90. doi: 10.1002/clc.4960270510. Clin Cardiol. 2004. PMID: 15188945 Free PMC article. Clinical Trial.
Adipocyte-derived leucine aminopeptidase genotype and response to antihypertensive therapy.
Hallberg P, Lind L, Michaëlsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H. Hallberg P, et al. Among authors: ohman kp. BMC Cardiovasc Disord. 2003 Sep 18;3:11. doi: 10.1186/1471-2261-3-11. Epub 2003 Sep 18. BMC Cardiovasc Disord. 2003. PMID: 13678427 Free PMC article. Clinical Trial.
Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study.
Nyström F, Malmqvist K, Ohman KP, Kahan T. Nyström F, et al. Among authors: ohman kp. J Hypertens. 2002 Aug;20(8):1527-33. doi: 10.1097/00004872-200208000-00015. J Hypertens. 2002. PMID: 12172314 Clinical Trial.
B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment: results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
Hallberg P, Lind L, Michaëlsson K, Karlsson J, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Melhus H. Hallberg P, et al. Among authors: ohman kp. J Hypertens. 2003 Mar;21(3):621-4. doi: 10.1097/00004872-200303000-00029. J Hypertens. 2003. PMID: 12640257 Clinical Trial.
Transforming growth factor beta1 genotype and change in left ventricular mass during antihypertensive treatment--results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA).
Hallberg P, Lind L, Billberger K, Michaelsson K, Karlsson J, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nyström F, Liljedahl U, Syvänen AC, Melhus H. Hallberg P, et al. Among authors: ohman kp. Clin Cardiol. 2004 Mar;27(3):169-73. doi: 10.1002/clc.4960270315. Clin Cardiol. 2004. PMID: 15049387 Free PMC article. Clinical Trial.
Regression of left ventricular hypertrophy in human hypertension with irbesartan.
Malmqvist K, Kahan T, Edner M, Held C, Hägg A, Lind L, Müller-Brunotte R, Nyström F, Ohman KP, Osbakken MD, Ostergern J. Malmqvist K, et al. Among authors: ohman kp. J Hypertens. 2001 Jun;19(6):1167-76. doi: 10.1097/00004872-200106000-00023. J Hypertens. 2001. PMID: 11403367 Clinical Trial.
Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients.
Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, Nyström F, Hägg A, Lind L; Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Trial. Kurland L, et al. Among authors: ohman kp. J Hypertens. 2001 Oct;19(10):1783-7. doi: 10.1097/00004872-200110000-00012. J Hypertens. 2001. PMID: 11593098 Clinical Trial.
A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima-media thickness of the carotid artery in hypertensive patients. The Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA).
Brändström H, Stiger F, Kahan T, Melhus H, Nyström F, öHman KP, Malmqvist K, Lind L, Kindmark A. Brändström H, et al. Among authors: ohman kp. Blood Press. 2004;13(3):152-7. doi: 10.1080/08037050410035563. Blood Press. 2004. PMID: 15223723 Clinical Trial.
64 results